Literature DB >> 22914503

Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial.

Venkatesh N Prajna, Prajna S Lalitha, Jeena Mascarenhas, Tiruvengada Krishnan, Muthiah Srinivasan, C M Vaitilingam, Catherine E Oldenburg, Aileen Sy, Jeremy David Keenan, Travis C Porco, Nisha R Acharya, Thomas M Lietman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22914503      PMCID： PMC3833089          DOI： 10.1136/bjophthalmol-2012-301825

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  Comparison of natamycin and voriconazole for the treatment of fungal keratitis.

Authors:  Namperumalsamy V Prajna; Jeena Mascarenhas; Tiruvengada Krishnan; P Ravindranath Reddy; Lalitha Prajna; Muthiah Srinivasan; C M Vaitilingam; Kevin C Hong; Salena M Lee; Stephen D McLeod; Michael E Zegans; Travis C Porco; Thomas M Lietman; Nisha R Acharya
Journal:  Arch Ophthalmol       Date:  2010-06

2.  Voriconazole and fungal keratitis: a report of two treatment failures.

Authors:  JoAnn A Giaconi; Fabiana B Marangon; Darlene Miller; Eduardo C Alfonso
Journal:  J Ocul Pharmacol Ther       Date:  2006-12       Impact factor: 2.671

Review 3.  Current perspectives on ophthalmic mycoses.

Authors:  Philip A Thomas
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

4.  Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.

Authors:  Prajna Lalitha; Brett L Shapiro; Muthiah Srinivasan; Namperumalsamy Venkatesh Prajna; Nisha R Acharya; Annette W Fothergill; Jazmin Ruiz; Jaya D Chidambaram; Kathryn J Maxey; Kevin C Hong; Stephen D McLeod; Thomas M Lietman
Journal:  Arch Ophthalmol       Date:  2007-06

5.  In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.

Authors:  Fabiana Bogossion Marangon; Darlene Miller; Joann A Giaconi; Eduardo C Alfonso
Journal:  Am J Ophthalmol       Date:  2004-05       Impact factor: 5.258
  5 in total
  6 in total

1.  Evolution of Practice Patterns for the Treatment of Fungal Keratitis.

Authors:  Catherine E Oldenburg; N Venkatesh Prajna; Abdou Amza; Allison Loh; Nisha R Acharya; Mark J Mannis; Thomas M Lietman
Journal:  JAMA Ophthalmol       Date:  2017-12-01       Impact factor: 7.389

2.  Fusarium Keratitis in Taiwan: Molecular Identification, Antifungal Susceptibilities, and Clinical Features.

Authors:  Tsung-En Huang; Jie-Hao Ou; Ning Hung; Lung-Kun Yeh; David Hui-Kang Ma; Hsin-Yuan Tan; Hung-Chi Chen; Kuo-Hsuan Hung; Yun-Chen Fan; Pei-Lun Sun; Ching-Hsi Hsiao
Journal:  J Fungi (Basel)       Date:  2022-05-03

3.  In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.

Authors:  Prajna Lalitha; Catherine Q Sun; N Venkatesh Prajna; Rajarathinam Karpagam; Manoharan Geetha; Kieran S O'Brien; Vicky Cevallos; Stephen D McLeod; Nisha R Acharya; Thomas M Lietman
Journal:  Am J Ophthalmol       Date:  2013-10-22       Impact factor: 5.258

4.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

Review 5.  Fusarium Keratitis-Review of Current Treatment Possibilities.

Authors:  Marek Szaliński; Aleksandra Zgryźniak; Izabela Rubisz; Małgorzata Gajdzis; Radosław Kaczmarek; Joanna Przeździecka-Dołyk
Journal:  J Clin Med       Date:  2021-11-23       Impact factor: 4.241

6.  Therapeutic Effect of Intrastromal Voriconazole, Topical Voriconazole, and Topical Natamycin on Fusarium Keratitis in Rabbit.

Authors:  Mahmood Nejabat; Nafiseh Yaqubi; Amir Khosravi; Kamiar Zomorodian; Mohammad Javad Ashraf; Ramin Salouti
Journal:  J Ophthalmol       Date:  2016-05-19       Impact factor: 1.909
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.